 |
 Video: What is a Stock Split?
|
|
|
| Myriad Genetics is genetic testing and precision medicine company. Co. provides insights that help people take control of their health and enable healthcare providers to detect, treat, and prevent disease. Co. discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, or guide treatment decisions across medical personnel. Co.'s molecular diagnostic tests are designed to analyze genes and their expression levels to assess an individual's risk for developing disease, determine a patient's likelihood of responding to a particular drug, or assess a patient's risk of disease progression. According to our MYGN split history records, Myriad Genetics has had 2 splits. | |
|
Myriad Genetics (MYGN) has 2 splits in our MYGN split history database. The first split for MYGN took place on September 12, 2000. This was a 2 for 1 split, meaning for each share of MYGN owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. MYGN's second split took place on March 26, 2009. This was a 2 for 1 split, meaning for each share of MYGN owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.
When a company such as Myriad Genetics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the MYGN split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Myriad Genetics shares, starting with a $10,000 purchase of MYGN, presented on a split-history-adjusted basis factoring in the complete MYGN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/07/2014 |
|
| End date: |
10/04/2024 |
|
| Start price/share: |
$37.47 |
|
| End price/share: |
$26.47 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-29.36% |
|
| Average Annual Total Return: |
-3.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$7,061.09 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 09/12/2000 | 2 for 1 | | 03/26/2009 | 2 for 1 |
|
|
Free MYGN Email Alerts:
